Mon – Fri | 8:00 am – 6:00 pm
Sat – Sun | closed

Tag: Esketamine

  • Signs You May Have Treatment-Resistant Depression

    Signs You May Have Treatment-Resistant Depression

    We understand just how challenging it is to live with depression. It is even more discouraging to take antidepressants for a period of time without experiencing any progress or relief. We want to assure you that your lack of response to medication is not
    a personal failure, and there is nothing wrong with you.


    At Optimum Mental Health Services in Renton, Washington, we see many people who face this exact situation. What you are dealing with is called treatment-resistant depression (TRD). Understanding it can help you have more self-compassion and find
    other kinds of treatment that fit you.

    What Exactly is Treatment-Resistant Depression?

    When you see one of our providers for depression, your treatment often starts with standard oral antidepressant medications, which are intended to balance brain chemistry over time. However, not everyone responds to treatment the same way, and the severe effects of depression can continue to persist. This is not unusual, as everyone reacts differently to different medications based on their biological makeup.


    Treatment-resistant depression is diagnosed when you have consistently taken the full prescribed dosage of at least two different types of antidepressants, but your symptoms have not decreased. This simply means that your baseline brain chemistry is distinct, and it requires a different kind of clinical approach to achieve stability.

    Signs Your Depression Treatment May Not Be Working

    It is important that you know the specific signs of treatment-resistant depression so that you can discuss them with your provider. You are our priority when we develop an effective care plan, because we value your lived experience. Pay attention to these specific daily experiences:

    1. Your Standard Symptoms Do Not Change

    The most direct sign is that the depressive symptoms you experienced before starting treatment remain unchanged, even after trying multiple prescriptions without improvement. Your current medication approach may not be working effectively if you
    still experience a very low mood, constant fatigue, appetite changes, and a lack of interest in things that previously brought you joy.

    2. You Only Feel Better for a Short Time, Then Relapse

    You might start a new prescription that makes you feel slightly better for a few weeks, but then you return to the same struggles you experienced at the beginning. Your mood can suddenly drop even when there are no external triggers, making it difficult to maintain long-term stability. This often means that your body is adjusting to the medication in a way that stops its therapeutic effects.

    3. The Side Effects Outweigh the Benefits

    Unfortunately, the physical side effects of psychiatric medications can be difficult to endure, especially when your emotional and mental state are not improving. Watch out for issues like dry mouth, weight changes, nausea, or sleep disruptions. If a medication
    causes significant physical discomfort without providing emotional relief, the treatment plan needs to be re-evaluated.

    4. Daily Responsibilities Still Feel Unmanageable

    We provide psychiatric care to help you manage your daily life as normally as possible. However, your current treatment plan may not be effective if your depression continuously prevents you from going to work, managing your household, taking care of your physical hygiene, or maintaining your relationships.

    The Solution You Need for Treatment-Resistant Depression: Spravato®

    The good news is that there is an effective medical option even when treatment-resistant depression makes you feel as though your choices are limited. We invite you to try Spravato® (esketamine) nasal spray, an FDA-approved medical treatment specifically for adults with treatment-resistant depression.


    At Optimum Mental Health Services, we are authorized to clinically administer this medication, so you can be confident that you are receiving experienced, professional care. Spravato® targets different pathways in the brain to provide relief from severe symptoms. Many individuals start to see an improvement in their depressive symptoms within 24 to 72 hours.


    Because Spravato® is a specialized medication, you must take it under direct clinical supervision at our Renton clinic. We recommend that you call or visit us for a consultation first so that you can fully understand how the treatment works and address any specific questions you have.

    Is Spravato® Covered by Insurance?

    A concern you may have is whether specialized medical treatments like Spravato® are covered by health insurance. The answer is yes; most major health insurance plans, including Medicare, do cover Spravato® for the treatment of treatment-resistant depression.


    At Optimum Mental Health Services, our dedicated administrative team manages the insurance approval process for you. We work directly with your insurance provider to complete the benefits verification and handle the required prior authorizations. Our team reviews your specific coverage details with you before you begin your sessions, helping you understand your exact copayments so there are no financial surprises.

    Contact Optimum Mental Health Services Today

    You may be nervous about starting Spravato® treatment, but we assure you that our clinical care team is here to support you during every session. Treatment-resistant depression can be managed effectively with Spravato®, and we are here to help you
    improve your symptoms and achieve long-term emotional stability.


    You can contact our office using the options below to verify your health insurance, ask
    questions, or set up your initial appointment.
    ● Primary Call or Text Line: (425) 233-0431
    ● Alternative Phone Line: (206) 312-2769
    ● Office Address: 15 South Grady Way, Suite 249, Renton, WA 98057
    ● Online Scheduling: Visit our Contact Page to fill out an online inquiry form, and our staff will help you get started.

  • Debunking common myths about Spravato

    Debunking common myths about Spravato

    Spravato is specifically approved for treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts, meaning it is for individuals who haven’t responded to at least two prior antidepressants. It’s not a last resort but rather an option for those needing a different approach to treatment. There are a lot of misconceptions about Spravato®, and we’re here to clear them up. This FDA-approved treatment for treatment-resistant depression is often misunderstood, leading to confusion about how it works and who it’s for. Let’s break down some myths and uncover the real facts so you can make informed decisions about your mental health.

    MYTH #1 — Spravato is not covered by insurance

    Many insurance plans, including Medicare, do cover Spravato. Our clinic takes care of the entire prior authorization process, working closely with insurers to streamline approvals and ensure a hassle-free experience for our clients.

    While some patients feel relief after just a few sessions, most see gradual changes over several weeks. Depression treatment isn’t one-size-fits-all.

    MYTH #2 — Spravato is only used as a last-resort treatment

    Spravato is specifically approved for treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts, meaning it is for individuals who haven’t responded to at least two prior antidepressants. It’s not a last resort but rather an option for those needing a different approach to treatment.

    MYTH #3 — Spravato works instantly for everyone

    While some patients feel relief after just a few sessions, most see gradual changes over several weeks. Depression treatment isn’t one-size-fits-all.

    MYTH #4 — Spravato is just like taking an antidepressant pill

    Unlike traditional SSRIs and SNRIs, Spravato works on NMDA receptors, offering a unique and faster-acting approach to treatment-resistant depression.

    MYTH #5 — Spravato is addictive like opioids

    While Spravato contains esketamine, a derivative of ketamine, it is not the same as recreational ketamine use and does not lead to physical dependence when used as prescribed. Spravato is administered in a controlled medical setting under supervision, greatly reducing the risk of misuse, and patients are carefully screened before starting treatment to ensure it is an appropriate and safe option.

    MYTH #6 — Spravato replaces the need for therapy or other treatments

    Spravato works best as part of a comprehensive treatment plan. It is not a standalone cure but is most effective when combined with therapy, lifestyle changes, and other medications as needed.

    MYTH #7 — Spravato and IV ketamine therapy are the same

    Both come from ketamine, but Spravato is FDA-approved, administered as a nasal spray, and requires clinical supervision. IV ketamine is not FDA-approved for depression and follows a different protocol.

    MYTH #8 — Spravato is dangerous for everyone with a history of substance use

    While Spravato has the potential for misuse, patients with a history of substance use can still be eligible if properly screened and monitored. Providers assess each patient’s history and develop a treatment plan to ensure safe use.

  • Let’s talk about treatment-resistant depression

    Let’s talk about treatment-resistant depression

    According to a 2021 study, out of the 8.9 million adults who take medication for major depressive disorder, approximately 2.8 million (30.9%) have treatment-resistant depression (TRD). Patients who have not had a positive response to two or more antidepressants from different classes can be considered as having treatment-resistant depression.

    If you have TRD and have not found relief, there is hope.

    image1

    Spravato is transforming the landscape for those with treatment-resistant depression, providing a beacon of hope where other therapies have fallen short. With its innovative approach, many are finding relief and a path toward brighter days.

    In a clinical trial, after four weeks of treatment, about 70% of patients had at least a 50% reduction in symptoms, and about 50% achieved complete remission from depressive symptoms.

    image2

    In a clinical trial, after four weeks of treatment, about 70% of patients had at least a 50% reduction in symptoms, and about 50% achieved complete remission from depressive symptoms.